Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Apr 30, 2025 | FY 2024Apr 30, 2024 | FY 2023Apr 30, 2023 | FY 2022Apr 30, 2022 | FY 2021Apr 30, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 351,768 | 387,350 | 497,560 | 578,622 | -- |
| General And Administrative Expense | 351,768 | 387,350 | 497,560 | 578,622 | -- |
| Other Operating Expenses | 324,880 | 288,770 | 195,571 | 186,251 | -- |
| Operating Expense | 676,648 | 676,120 | 693,131 | 764,873 | -- |
| Operating Income | -676,648 | -676,120 | -693,131 | -764,873 | -- |
| EBIT | -676,648 | -676,120 | -693,131 | -764,873 | -- |
| Other Income Expense | -769,967 | -103,546 | -36,205 | 13,521 | -- |
| Other Non Operating Income Expenses | 21,875 | 44,206 | 95,794 | 13,521 | -- |
| Special Income Charges | -661,842 | -147,752 | -131,999 | 0.00 | -- |
| Write Off | -- | 0.00 | 12,745 | 0.00 | -- |
| Gain On Sale Of Security | -130,000 | -- | -- | -- | -- |
| Pretax Income | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| Net Income From Continuing Operation Net Minority Interest | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| Net Income Including Noncontrolling Interests | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| Net Income Common Stockholders | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| Net Income | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| EBITDA | -676,648 | -676,120 | -693,131 | -764,873 | -- |
| Normalized EBITDA | 115,194 | -528,368 | -561,132 | -764,873 | -- |
| Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -- |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -- |
| Basic Average Shares | 101.7M | 82.2M | 70.6M | 60.5M | -- |
| Diluted Average Shares | 101.7M | 82.2M | 70.6M | 60.5M | -- |
| Total Unusual Items | -791,842 | -147,752 | -131,999 | 0.00 | -- |
| Total Unusual Items Excluding Goodwill | -791,842 | -147,752 | -131,999 | 0.00 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -654,773 | -631,914 | -597,337 | -751,352 | -- |
| Diluted NI Availto Com Stockholders | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| Gain On Sale Of Ppe | -- | 0.00 | -119,254 | 0.00 | -- |
| Impairment Of Capital Assets | 661,842 | 147,752 | 0.00 | -- | -- |
| Insurance And Claims | 14,938 | 14,912 | 9,939 | 7,722 | -- |
| Net Income Continuous Operations | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| Other Gand A | 336,830 | 360,238 | 487,621 | 384,900 | -- |
| Salaries And Wages | 0.00 | 12,200 | 0.00 | 186,000 | -- |
| Total Expenses | 676,648 | 676,120 | 693,131 | 764,873 | -- |
| Total Operating Income As Reported | -676,648 | -676,120 | -693,131 | -764,873 | -- |
| Line Item | FY 2025Apr 30, 2025 | FY 2024Apr 30, 2024 | FY 2023Apr 30, 2023 | FY 2022Apr 30, 2022 | FY 2021Apr 30, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 335,200 | 189,192 | 66,597 | 49,756 | -- |
| Cash Cash Equivalents And Short Term Investments | 335,200 | 189,192 | 66,597 | 49,756 | -- |
| Cash Financial | 335,200 | 189,192 | 66,597 | 49,756 | -- |
| Receivables | 18,671 | 18,355 | 59,771 | 131,109 | -- |
| Prepaid Assets | -- | -- | -- | -- | 0.00 |
| Current Assets | 353,871 | 207,547 | 126,368 | 180,865 | -- |
| Net PPE | 38,607 | 650,619 | 744,992 | 1.2M | -- |
| Investments And Advances | 370,000 | 500,000 | 0.00 | -- | -- |
| Total Non Current Assets | 408,607 | 1.2M | 1.2M | 1.2M | -- |
| Total Assets | 762,478 | 1.4M | 1.4M | 1.4M | -- |
| Accounts Payable | 1.3M | 872,641 | -- | -- | -- |
| Payables | 1.3M | 872,641 | -- | -- | -- |
| Payables And Accrued Expenses | 1.3M | 872,641 | 411,455 | 344,909 | -- |
| Other Current Liabilities | 144,426 | 11,875 | 44,206 | -- | 13,521 |
| Current Liabilities | 1.4M | 884,516 | 455,661 | 344,909 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 1.4M | 884,516 | 455,661 | 344,909 | -- |
| Common Stock | 13.8M | 13.6M | 13.3M | 12.8M | -- |
| Capital Stock | 13.8M | 13.6M | 13.3M | 12.8M | -- |
| Additional Paid In Capital | 2.7M | 2.6M | 2.5M | 2.5M | -- |
| Retained Earnings | -17.1M | -15.7M | -14.9M | -14.2M | -- |
| Common Stock Equity | -684,762 | 473,650 | 915,699 | 1.1M | -- |
| Stockholders Equity | -684,762 | 473,650 | 915,699 | 1.1M | -- |
| Total Equity Gross Minority Interest | -684,762 | 473,650 | 915,699 | 1.1M | -- |
| Total Capitalization | -684,762 | 473,650 | 915,699 | 1.1M | -- |
| Net Tangible Assets | -684,762 | 473,650 | 915,699 | 1.1M | -- |
| Tangible Book Value | -684,762 | 473,650 | 915,699 | 1.1M | -- |
| Working Capital | -1.1M | -676,969 | -329,293 | -164,044 | -- |
| Invested Capital | -684,762 | 473,650 | 915,699 | 1.1M | -- |
| Share Issued | 110.4M | 97.4M | 79.7M | 64.5M | -- |
| Ordinary Shares Number | 110.4M | 97.4M | 79.7M | 64.5M | -- |
| Available For Sale Securities | 370,000 | 500,000 | -- | -- | -- |
| Investmentin Financial Assets | 370,000 | 500,000 | 0.00 | -- | -- |
| Non Current Accounts Receivable | -- | -- | 500,000 | -- | -- |
| Other Receivables | 18,671 | 18,355 | 59,771 | 131,109 | -- |
| Line Item | FY 2025Apr 30, 2025 | FY 2024Apr 30, 2024 | FY 2023Apr 30, 2023 | FY 2022Apr 30, 2022 | FY 2021Apr 30, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -236,295 | -170,073 | -405,062 | -512,779 | -- |
| Cash Flow From Continuing Operating Activities | -236,295 | -170,073 | -405,062 | -512,779 | -- |
| Stock Based Compensation | 0.00 | 12,200 | 0.00 | 186,000 | -- |
| Change In Working Capital | 440,353 | 493,847 | 300,814 | 66,094 | -- |
| Change In Receivables | -316.00 | 41,415 | 71,338 | 5,387 | -- |
| Change In Payables And Accrued Expense | 440,669 | 452,432 | 229,476 | 60,707 | -- |
| Other Non Cash Items | 108,125 | -44,206 | -95,794 | -13,521 | -- |
| Capital Expenditure | -30,828 | -44,624 | -411,014 | -322,966 | -- |
| Purchase Of PPE | -30,828 | -44,624 | -411,014 | -322,966 | -- |
| Net PPE Purchase And Sale | -30,828 | -44,624 | -311,014 | -322,966 | -- |
| Investing Cash Flow | -30,828 | -44,624 | -234,931 | -266,095 | -- |
| Cash Flow From Continuing Investing Activities | -30,828 | -44,624 | -234,931 | -266,095 | -- |
| Issuance Of Capital Stock | 456,500 | 389,975 | 828,200 | 646,900 | -- |
| Net Common Stock Issuance | 456,500 | 389,975 | 828,200 | 646,900 | -- |
| Financing Cash Flow | 413,131 | 337,292 | 656,834 | 622,917 | -- |
| Cash Flow From Continuing Financing Activities | 413,131 | 337,292 | 656,834 | 622,917 | -- |
| Changes In Cash | 146,008 | 122,595 | 16,841 | -155,957 | -- |
| Beginning Cash Position | 189,192 | 66,597 | 49,756 | 205,713 | -- |
| End Cash Position | 335,200 | 189,192 | 66,597 | 49,756 | -- |
| Free Cash Flow | -267,123 | -214,697 | -816,076 | -835,745 | -- |
| Asset Impairment Charge | 661,842 | 147,752 | 0.00 | -- | -- |
| Change In Prepaid Assets | -- | -- | -- | 0.00 | 21,600 |
| Common Stock Issuance | 456,500 | 389,975 | 828,200 | 646,900 | -- |
| Gain Loss On Sale Of PPE | -- | 0.00 | 119,254 | 0.00 | -- |
| Net Income From Continuing Operations | -1.4M | -779,666 | -729,336 | -751,352 | -- |
| Net Other Financing Charges | -43,369 | -52,683 | -171,366 | -50,233 | -- |
| Net Other Investing Changes | -- | -- | 76,083 | 56,871 | -- |
| Operating Gains Losses | -- | -- | 119,254 | -- | -- |
| Proceeds From Stock Option Exercised | -- | -- | 0.00 | 26,250 | 0.00 |
| Sale Of PPE | -- | 0.00 | 100,000 | 0.00 | 0.00 |